Effect of 1 565 nm non-ablative fractional laser on enlarged facial pores
10.3760/cma.j.issn.1671-0290.2024.05.020
- VernacularTitle:1 565 nm非剥脱点阵激光治疗面部毛孔粗大的效果
- Author:
Yang SHAO
1
;
Xin WANG
;
Ruibin HU
;
Danya ZHOU
;
Liang ZHU
;
Tianxiang HUANG
Author Information
1. 宁波市第六医院整形修复重建外科，宁波 315000
- Keywords:
Enlarged facial pores;
Non-ablative laser;
VISIA;
Adverse reaction
- From:
Chinese Journal of Medical Aesthetics and Cosmetology
2024;30(5):515-517
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the application of 1 565 nm non-ablative fractional laser in the treatment of enlarged facial pores.Methods:It was a longitudinal cohort study. From September 2020 to September 2021, 68 patients with enlarged facial pores, including 5 male patients and 63 female patients, aged between 20 and 41 (29.3±4.6) years, were treated at the Department of Plastic and Reconstructive Surgery of Ningbo Sixth Hospital. They received 1 565 nm non-ablative fractional laser once every month for a total of 3 times. The number, score and percentile ranking of facial pores before and after treatment were recorded and compared by VISIA, and adverse reactions were observed.Results:The facial pores number before and after treatment were 890.75±312.61 and 834.37±289.94, the facial pores score were 25.76±1.08 and 24.81±8.59, respectively, indicating a statistically significant decrease in facial pores number and score compared to before treatment ( t=4.19, 2.65, P<0.05). The facial pores percentile ranking before and after treatment were 4.00% (2.00%, 7.00%) and 5.00% (2.25%, 8.00%), respectively, indicating a statistically significant increase in facial pores percentile ranking compared to before treatment ( Z=-3.35, P<0.05). Three patients had transient pigmentation, all of which were gradually faded within 1 month after the last treatment. One patient had a few inflammatory papules scattered on the cheek, which faded in 3 days by using erythromycin eye cream. Conclusions:The 1 565 nm non-ablative laser can effectively improve enlarged facial pores with light adverse reactions.
